GKOS

Glaukos
GKOS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$5.36B
EV
$5.14B
Shares Outstanding
58.58M
Beta
0.88

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$151.62
P/E 2025E
-
P/Revenue 2025E
11.16x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Glaukos Corporation

gainify
GKOS

Glaukos Corporation

GKOS

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhanc...

Sector

Healthcare

Industry

Medical - Devices

CEO

Burns, Thomas

Employees

995

IPO Date

2015-06-25

Headquarters

One Glaukos Way, Aliso Viejo, California, 92656, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved